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Strongyle parasites are ubiquitous in grazing horses. Strongylus vulgaris, the most pathogenic 
of the large strongyles, is known for its extensive migration in the mesenteric arterial system. 
The lifecycle of S. vulgaris is characterised by a long prepatent period where the migrating 
larvae are virtually undetectable as there currently is no test available for diagnosing 
prepatent S. vulgaris infection. Presence of S. vulgaris larvae in the arterial system causes 
endarteritis and thrombosis with a risk of non-strangulating intestinal infarctions. Emergence 
of anthelmintic resistance among cyathostomins has led to recommendations of reduced 
treatment intensity by targeting horses that exceed a predetermined strongyle faecal egg count 
threshold. One study suggests an apparent increase in prevalence of S. vulgaris on farms 
where reduced anthelmintic treatment intensity has been implemented. These issues highlight 
the need for an accurate and reliable assay for diagnosing prepatent S. vulgaris infection. 
Methods 
Immunoscreening of a larval S. vulgaris cDNA library using hyperimmune serum raised 
against S. vulgaris excretory/secretory antigens was performed to identify potential 
diagnostic antigens. Immunoreactive clones were sequenced, one potential antigen was 
characterised, expressed as a recombinant protein, initially evaluated by western blot (WB) 
analysis, the diagnostic potential of the IgG subclasses was evaluated by ELISA, and the 
diagnostic accuracy evaluated using serum from 102 horses with known S. vulgaris infection 
status. 
Results 
The clone expressing the potential antigen encoded a S. vulgaris SXP/RAL2 homologue. The 
recombinant protein, rSvSXP, was shown to be a potential diagnostic antigen by WB 
analysis, and a target of serum IgGa, IgG(T) and total IgG in naturally infected horses, with 
IgG(T) antibodies being the most reliable indicator of S. vulgaris infection in horses. 
Evaluation of diagnostic accuracy of the ELISA resulted in a sensitivity of 73.3%, a 
specificity of 81.0%, a diagnostic odds ratio of 11.69; a positive likelihood ratio (LR) of 3.85 
and a negative LR was 0.33. The area under the ROC curve was 0.820. 
Conclusion 
IgG(T) antibodies to recombinant SvSXP show potential for use as an antigen for prepatent 
diagnosis of migrating stages of S. vulgaris with moderate to good diagnostic accuracy. 
Keywords 
SXP, IgG(T), Strongylus vulgaris, Prepatent, Diagnosis, cDNA library, ELISA, Validation 
Background 
Strongyle parasites are ubiquitous in grazing horses with more than 50 different species 
described [1]. The most pathogenic of the equine gastrointestinal parasites is Strongylus 
vulgaris. The prepatent period of S. vulgaris is 6–7 months [2], and during this time, the 
larvae migrate in the Cranial Mesenteric Artery (CMA) and major branches [3,4]. Here, the 
larvae cause verminous endarteritis [5-7], and subsequent thromboembolism can cause a 
painful non-strangulating infarction of the intestinal tract [3,8]. 
Prior to the advent of modern paste-based dewormers, S. vulgaris was present in about 80–
100% of horses [9,10], but frequent interval-dose anthelmintic regimens appear to have 
caused a dramatic reduction in prevalence [11,12]. However, these frequent treatments have 
led to anthelmintic resistance in other parasite categories infecting horses; cyathostomins [13-
15] and Parascaris equorum [16-18], and recommendations are now given to reduce 
treatment intensity by basing control programs on systematic parasite surveillance [19-21]. In 
the European Union, prescription-only restrictions on anthelmintic drugs have been or are 
being implemented by legislation of member countries [22]. Experiences with prescription-
only restrictions in Denmark show that a reduction in treatment intensity follows [23]. A 
recent study performed in this country suggested that these anthelmintic treatment policies 
may have contributed to a higher prevalence of S. vulgaris [24]. Given the high pathogenicity 
of this parasite, there is a need for improved diagnostic assays to better diagnose and monitor 
this parasite while maintaining anthelmintic efficacy in equine populations. 
Currently, diagnosis of S. vulgaris infection is based on the presence of eggs shed in faeces of 
infected horses, and is accomplished by either larval culture and subsequent microscopic 
examination [25,26] or by a semi-quantitative PCR detecting DNA extracted from the eggs 
[27]. So far, no test has been developed to accurately diagnose the presence of migrating 
larvae in the CMA and branches [Reviewed by [28]]. 
Several attempts have been made to develop a serological test for the diagnosis of prepatent 
S. vulgaris infection. In the last three decades, whole worm extracts, surface antigen extracts 
and excretory/secretory (ES) antigens have been evaluated for use in diagnostic assays [29-
33]. Wynne and co-workers [29] evaluated different tissue extracts and ES antigens by use of 
hyperimmune rabbit sera raised against the different antigenic fractions. This led to the 
discovery of two species-specific and one stage-specific ES antigen, but these were not 
evaluated with serum from horses naturally or experimentally infected with S. vulgaris. Thus 
the full diagnostic potential of these antigens remains unknown. Klei et al. [30] evaluated the 
unspecific antibody response in previously helminth-naïve foals that were experimentally 
infected with S. vulgaris. These workers developed an indirect fluorescent antibody (IFA) 
assay and discovered that these foals developed a species-specific response to S. vulgaris L3-
larvae with no cross-reactivity with S. edentatus, S. equinus, or cyathostomins. However, 
evaluation of hyperimmune rabbit sera raised against S. edentatus and S. equinus antigens 
showed that these cross-reacted with S. vulgaris larvae; in fact both sera reacted more 
strongly against S. vulgaris larvae than S. edentatus or S. equinus larvae. Therefore, the IFA 
was never validated as a diagnostic test. Nichol and Masterson [31] evaluated S. vulgaris 
surface antigen extracts and found them to show a high degree of cross-reactivity with the 
closely related S. edentatus and the more distantly related Parascaris equorum. Affinity 
chromatography was performed to remove cross-reactive antibodies from the hyperimmune 
rabbit serum and three antigens were found to be potential diagnostic antigens. Adeyefa [32] 
evaluated somatic extracts using the IgG(T) fraction of serum from horses naturally infected 
with gastrointestinal helminths including arterial S. vulgaris larvae and found two potential 
diagnostic antigens. Cross-reactivity with other gastrointestinal helminths was, however, not 
assessed. Hassan et al. [33] recently evaluated adult somatic antigen and found the ELISA to 
detect more positive samples than the larval culture. No horses were necropsied for 
determination of true infection status, and ELISA results were only compared to larval 
cultures, so diagnostic performance cannot be assessed [33]. Taken together, none of the 
potential antigens described here were fully evaluated or validated as diagnostic tests, and 
most of them were not fully characterized. The antigens discovered by Nichol and Masterson 
[31] were the only antigens to be isolated and expressed in vitro [31], but sera from naturally 
infected horses failed to recognise these. No attempt has been made to clone the S. vulgaris 
antigen or express recombinantly for incorporation into a diagnostic test. 
Recently, a molecular approach was employed for identifying candidate molecules for 
prepatent diagnosis of another important parasite group infecting horses; larval 
cyathostomins. This included immunoscreening of a cDNA library constructed from encysted 
cyathostomin larvae and allowed identification of a promising antigen to be evaluated as a 
candidate for diagnosing encysted cyathostomin larvae [34]. This protein was found to be 
stage-specific as it is only expressed in the larval stages of the cyathostomins. 
This study employed immunoscreening of a S. vulgaris larval cDNA library to identify genes 
that encode potential diagnostic antigens. The aims were to subsequently explore the use of 
these in immunodiagnostic assays for a diagnosis of prepatent S. vulgaris infection, to 
evaluate the inter- and intra-assay variability, the diagnostic properties, as well as the 
quantitative aspects of the assay. 
Methods 
Horses 
A total of 102 horses with necropsy-confirmed status of S. vulgaris infection were enrolled in 
the validation study. All necropsies were performed at either University of Kentucky in 
Lexington, Kentucky or East Tennessee Clinical Research (ETCR) in Rockwood, Tennessee. 
All horses from University of Kentucky were naturally infected with mixed species of 
gastrointestinal helminth infections (n=31). They were enrolled from two main populations; a 
herd kept without anthelmintic intervention since 1979 [35], and a population of research 
horses maintained with four anthelmintic treatments a year. Naturally infected horses from 
Tennessee (n=23) participated in different anthelmintic drug trials at ETCR and all underwent 
necropsy. In total, samples from 54 naturally infected horses were collected. 
Experimental infections were carried out for two different research projects with horses 
maintained at ECTR (n=48). Horses in group P (n=20) were treated once daily for five 
consecutive days with fenbendazole paste (10 mg/kg, Panacur, Merck, Summit, NJ, USA), 
housed in stables and inoculated on a single occasion with 600 embryonated P. equorum eggs 
obtained locally from naturally infected horses. After six months the horses were 
euthanatised and necropsied. Horses in group S (n=28) were acquired with unknown 
anthelmintic treatment history, and were therefore treated with a larvicidal regimen of 
moxidectin (0.4 µg/kg, Quest gel, Pfizer, Madison, NJ, USA) administered once, and 
fenbendazole paste (10 mg/kg, Panacur) once daily for five consecutive days during the week 
prior to enrolment in the study. They were subsequently infected with 5,000 cyathostomin 
third stage larvae (L3) five times weekly throughout the study. Five weeks into the study the 
horses started receiving 25 S. vulgaris L3 larvae once weekly until euthanasia and necropsy 
after 5.5 months [36]. 
At necropsy, the posterior aorta and cranial mesenteric artery and branches were recovered 
and evaluated for the presence of migrating S. vulgaris larvae in all horses. 
The case-definition that served as the gold standard for classification of S. vulgaris positive 
horses was: horses with migratory tracts, one or more larvae, or evidence of previous 
infection. Migratory tracts were considered evidence of a current infection, and a circular area 
with raised surface, roughened or corrugated intima without evidence of active thrombosis 
was classified as evidence of previous infection. Horses with no migratory tracts, no larvae, 
and no signs of previous infection were classified as being S. vulgaris-negative. 
The gastrointestinal and migrating parasites were enumerated as previously described [37]. 
A peripheral blood sample was collected from each horse (n=102) in a serum or serum-
separator tube. Sera were separated by centrifugation, and duplicate aliquots were transferred 
to 2 mL cryovials and stored at −20°C until analysis. The serum was stored for up to 5 years 
prior to analysis. 
The horses in this study had a mean age of 19.5 months (range 0.6 months – 22 years) with a 
median of 12 months of age. A total of 46 horses were female and 54 were males of which 12 
were castrated. Data on age and gender was missing for two and one horse, respectively. The 
subset of horses 7 months and older had a mean age of 22.51 months (range 7 months – 22 
years) with a median of 18 months of age with 44 female, 42 males of which 12 were 
castrated. Data from horses 3 months and younger were omitted; the next youngest foal was 7 
months old. Breeds represented included: Tennessee Walking Horse, Paint, American 
Quarter Horse, Thoroughbred, Standardbred, Appaloosa, Shetland type ponies and mixed 
light breed. 
All work involving the horses at UK and ETCR was approved by the Institutional Animal 
Care and Use Committee. 
Parasite material 
Migrating S. vulgaris larvae were collected by dissection of the abdominal aorta, celiac 
artery, cranial mesenteric artery and major branches recovered from horses at the University 
of Kentucky that were naturally infected with gastrointestinal parasites and where 
anthelmintic drugs have not been used since 1979 [35]. The larvae were carefully lifted from 
the thrombus material and washed four times in 20 mL PBS (137 mM NaCl, 10 mM 
phosphate, 2.7 mM KCl, pH 7.4) to remove debris. The larvae were either placed in 2 mL 
cryotubes and snap frozen in liquid N2 for RNA extraction or used for collection of ES 
antigens. 
Worms were collected from the caeca of horses using the necropsy technique previously 
described [37], adult S. vulgaris worms were identified by morphological criteria [1] and 
washed five times in 20 mL PBS to remove debris and used for collection of ES antigens. 
Excretory/secretory antigens 
Living washed adult worms were incubated in 5 mL RPMI-1640 (Life Technologies, Grand 
Island, NY, USA) with penicillin (100 IU/mL), streptomycin (100 IU/mL), amphotericin B 
(0.25 µg/mL) and a protease inhibitor cocktail (Protease inhibitor cocktail, P2714, Sigma-
Aldrich, St. Louis, MO, USA) in a 5% CO2 incubator at 37°C. The medium was collected 
after 12 and 24 h and fresh medium was added. The protein concentration was analysed using 
the Bradford Protein quantitation assay (Pierce, Rockford, IL, USA) as per the 
manufacturer’s protocol. The ES antigen-rich medium was then dialysed against PBS at 4°C 
using a 3 mL 3.5 kDa molecular cut-off Slide-A-Lyzer® (Pierce, Rockford, IL, USA) 
according to the manufacturer’s protocol. Dialysed ES antigen was frozen and shipped to 
Cocalico Biologicals, Inc. (Reamstown, PA, USA) for production of hyperimmune serum. 
One rat was immunised with 250 µg adult S. vulgaris ES antigen mixed with Titermax® as 
adjuvant and given as six inoculations over a 61-day period. Due to background reactivity 
against E. coli proteins, the hyperimmune rat serum was pre-absorbed extensively against E. 
coli XL1-BLUE lysates [38]. 
Larval ES antigens were obtained from S. vulgaris larvae using 2 mL of RPMI-1640 (Life 
Technologies, Grand Island, NY, USA) with penicillin (100 IU/mL), streptomycin (100 
IU/mL), amphotericin B (0.25 µg/mL) and a protease inhibitor cocktail (Protease inhibitor 
cocktail, P2714, Sigma-Aldrich, St. Louis, MO, USA) and incubating the larvae in a 5% CO2 
incubator at 37°C. The medium was collected after 14 days during which time the dead larvae 
were removed daily with a sterile needle. 
A total of 300 ng of S. vulgaris larval ES antigens was adjusted to 15 µL with water and 
mixed with 3 µL 5X sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer containing protease inhibitor cocktail. The same amount of S. vulgaris 
adult ES was prepared similarly. The ES mixtures were denatured at 95°C for 5 min, placed 
on ice for 5 min and resolved in individual wells under reducing conditions in a 12% 
polyacrylamide gel, where after the gel was stained by silver staining. 
Construction and immunoscreening of a larval S. vulgaris cDNA library 
RNA was extracted from N2 frozen S. vulgaris larvae using the Trizol reagent (Life 
Technologies, Grand Island, NY, USA) and poly(A)+ RNA (mRNA) was purified from total 
RNA using the NucleoTrap® mRNA-kit (Clontech, Mountain View, CA, USA) according to 
the manufacturer's protocol. A total of 400 ng purified mRNA was used as template to 
synthesise cDNA using the SMART cDNA library construction kit (Clontech, Mountain 
View, CA, USA), cloned into bacteriophage TriplEx2 lambda vector digested with NdeI and 
packaged using the Giga Pack III gold packaging extract (Agilent Technologies, Stratagene 
products division, La Jolla, CA, USA) as previously described for a larval cyathostomin 
cDNA library [34]. The titre of the cDNA library was evaluated and the quality was assessed 
by analysing cDNA inserts in 30 randomly-picked plaques by PCR analysis. The PCR 
products were cleaned using the Wizard® SV Gel and PCR clean-up system (Promega, 
Madison, WI, USA) and sequenced at the University of Kentucky’s Advanced Genetic 
Technology Center. 
The S. vulgaris larval cDNA library was immunoscreened as described by the manufacturer 
(Clontech, Mountain View, CA, USA). The primary immunoscreening was conducted on 
100,000 cDNA clones. Plaque lifts were made onto nitrocellulose membranes (Fisher 
Scientific, Pittsburg, PA, USA) and the membranes were washed five times for 5 min in 25 
mL TBST (100 mM Tris, 0.15 M NaCl and 0.05% Tween-20) and kept in TBST overnight at 
4°C. The membranes were blocked with TBST + 1% gelatine for 1 h at room temperature 
(RT) and probed with preabsorbed hyperimmune rat serum at 1:100 in TBST after washing. 
As secondary antibodies, horseradish peroxidase (HRP)-conjugated goat anti-rat IgG (H+L) 
(Jackson ImmunoResearch, Inc. West Grove, PA, USA) were used at 1:10,000 in TBST after 
washing. The signal was developed using a chromogenic substrate (TMB stabilised substrate 
for HRP, Promega, Madison, WI, USA) after washing. The membranes were aligned with the 
agar plate, and the positive clones were picked using p200 pipette tips. The selected plaque 
was placed in 500 µL Lambda dilution buffer (0.1 M NaCl, 10 mM MgSO4, 3.5 mM Tris and 
0.01% gelatin), vortexed for 30 s and kept at 4°C. The positive clones underwent secondary 
immunoscreening with the hyperimmune rat serum and rat-pre-immunisation serum as 
negative control to exclude false positive clones. 
Sequence analyses 
Clones isolated from the cDNA library were amplified by PCR using vector-specific primers 
and sequenced at the University of Kentucky’s Advanced Genetic Technology Center. The 
resulting sequences were used as queries in BLASTN searches against non-human, non-
mouse nucleotide sequences and BLASTX searches against the non-redundant protein 
database from NCBI. The presence of a signal peptide was predicted using SignalP 4.0 [39], 
the presence of glycosylation sites were analysed using the ExPASy Prosite [40] and the 
presence of transmembrane domains and protein localisation were predicted using TMHMM 
2.0 server [41]. Pairwise alignment and phylogenetic comparison was performed using the 
ClustalOmega software on the EBI-server [42]. Homologues from Cylicostephanus goldi 
(courtesy of Dr. Jane Hodgkinson, University of Liverpool) and P. equorum (courtesy of Dr. 
Georg von Samson-Himmelstjerna, University of Berlin) were obtained and the partial 
sequences compared by pairwise alignment using the ClustalOmega software. 
Expression of recombinant protein 
Primers were designed to amplify the coding sequence from an immune-reactive cDNA clone 
for subcloning into a pET22b(+) vector. The primer sequences were as follows: Forward: 5’-
GATCCATATGCAAAATGGACCTCCACC-3' and reverse: 5'-
GATCCTCGAGTCCCTTCATAGCGTCC-3' which incorporated the NdeI and XhoI 
restriction sites (underlined) to allow for unidirectional cloning. The PCR was performed 
using Verbatim High Fidelity Polymerase (Thermo Fisher Scientific, Pittsburg, PA, USA) 
and the amplified fragment was digested with NdeI and XhoI and ligated with the pET22b(+) 
plasmid. The resulting plasmid was transformed into E. coli BL21 cells and expression of the 
recombinant protein was induced by 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at an 
OD600nm of 0.6 and the cells were incubated under agitation for 9 h at 30°C. The recombinant 
protein was purified on immobilised cobalt by affinity chromatography using BD TALON 
resin (Clontech, Mountain View, CA, USA) as per the manufacturer’s protocol for soluble 
proteins. Purified recombinant protein was stored in aliquots at −20°C. 
Hyperimmune serum against recombinant protein 
A total of 300 µg of recombinant protein was resolved in 12% polyacrylamide gels under 
reducing conditions, a strip of the gel was stained with GelCode Blue stain (Thermo 
Scientific, Pittsburg, PA, USA) to verify where the recombinant antigen travelled in the gel 
and the corresponding part of the gel containing the desired molecular size was cut out and 
shipped to Cocalico Biologicals, Inc. (Reamstown, PA, USA) and used to immunise a guinea 
pig with Freund’s complete adjuvant for initial immunisation and Freund’s incomplete 
adjuvant for subsequent boosters. The guinea pig was immunised by 6 inoculations of 
recombinant antigen over a period of 17 weeks. 
Western blot analyses 
S. vulgaris ES 
For Western blot (WB) analysis of anti-adult S. vulgaris ES rat serum against both S. vulgaris 
larval and adult ES antigens were mixed with SDS-PAGE sample buffer containing protein 
inhibitor cocktail under reducing conditions and resolved in two 1-well 12% polyacrylamide 
gels. The proteins were transferred to 0.45 µm nitrocellulose membranes by semidry 
electrophoretic transfer in Tris-glycine buffer. Membranes were blocked for 1 h in PBST 
(PBS + 0.05% Tween-20), and probed with pre-immunisation rat serum at 1:100 in PBST or 
hyperimmune rat serum raised against S. vulgaris adult ES at 1:100 in PBST. The signal was 
developed using TMB stabilised substrate for HRP (Promega, Madison, WI, USA). 
For WB analysis of anti-recombinant protein guinea pig serum against larval ES, 4.4 µg S. 
vulgaris larval ES was resolved in a 1-well 12% polyacrylamide gels, transferred to a 
nitrocellulose membrane and blocked. The nitrocellulose membrane was cut and strips were 
placed in individual trays. The strips were probed with either 500 µL of guinea pig pre-
immunisation serum at 1:500 in PBST or guinea pig hyperimmune serum anti-recombinant 
protein at 1:2,500 in PBST. HRP-conjugated goat anti-horse IgG(T) (Bethyl Laboratories, 
Inc., Montgomery, TX, USA), were used as secondary antibodies at 1:10,000 in PBST. The 
signal was developed using Supersignal WestPico chemiluminescent substrate (Pierce, 
Rockford, IL, USA). 
Recombinant protein 
Recombinant protein (233 ng) was resolved in each of two 1-well 12% polyacrylamide gels 
by SDS-PAGE under reducing conditions and transferred to nitrocellulose membranes. The 
membranes were blocked and one was placed in a multi-slot apparatus (Bio Rad, Hercules, 
CA, USA). The blot was probed with 500 µL horse serum samples (1:50 in PBST) in each 
slot. As secondary antibodies, HRP-conjugated goat anti-horse IgG(T) (Bethyl Laboratories, 
Inc., Montgomery, TX, USA), were used at 1:10,000 in PBST. The signal was developed 
using Supersignal WestPico chemiluminescent substrate. 
Strips were cut from the other blocked blot and placed in individual trays. The strips were 
probed with either pre-immunisation guinea pig serum at 1:500 in PBST or anti-recombinant 
protein guinea pig serum at 1:2500 in PBST. As secondary antibody, HRP-conjugated 
donkey anti-guinea pig IgG (H+L) (Jackson ImmunoResearch, Inc., West Grove, PA, USA) 
were used at 1:10,000 in PBST. The signal was developed using Supersignal WestPico 
chemiluminescent substrate. 
ELISA 
The indirect ELISA was optimised by sequential checkerboard titration to the following 
setup. Individual wells of a 96 well EIA/RIA plate (Costar® easy-wash, Corning Inc., 
Corning, NY, USA) were coated with 75 µL of recombinant protein diluted to 0.1 µg/mL in 
PBS and incubated overnight at 4°C. The wells were washed three times for 1 min with 
PBST and blocked for 1½ h at RT with 200 µL block solution (PBS containing 5% normal 
goat serum, 1% dry milk powder and 1% Tween-20). The wells were washed once and 75 µL 
of horse serum diluted 1:50 in diluent solution (block solution in PBST, 1:10) was added to 
individual wells in duplicates and incubated for 1 h at 37°C. Positive, negative and blank 
controls were included on each plate in duplicates. The wells were washed five times with 
PBST, and 75 µL of HRP-conjugated goat anti-horse IgG (H+L) (Jackson ImmunoResearch, 
Inc. West Grove, PA, USA) diluted 1:10,000 was added to each well and incubated for 1 h at 
37°C. The wells were washed five times with PBST and incubated for 10 min at RT in the 
dark with 75 µL of RT 1-step Ultra TMB ELISA substrate (Thermo Scientific, Rockford, IL, 
USA) per well. The reactions were stopped with 75 µL 2 M H2SO4 per well, and the OD450nm 
determined using an E-max Precision Microplate Reader (Molecular Devices, Sunnyvale, 
CA, USA) with a photometric range of 0.000 to 4.000 OD and a resolution of 0.001 OD. 
IgG subclass antibodies 
For evaluation of the optimal diagnostic antibody target in serum from 15 horses with known 
S. vulgaris larval infection status, the level of antigen specific IgG subclasses IgGa, IgGb, 
IgGc and IgG(T) were evaluated using HRP-conjugated goat anti-horse IgGa, IgGb, IgGc and 
IgG(T) antibodies (Bethyl Laboratories, Inc., Montgomery, TX, USA) at 1:40,000 as 
secondary antibodies as per the manufacturer’s recommendation alongside the HRP-
conjugated goat anti-horse IgG (H+L) secondary antibody as described in the ELISA setup. 
After identifying the best antibody target, the secondary antibody dilution for the ELISA was 
optimised by checkerboard titration. 
Diagnostic accuracy of ELISA 
These ELISAs were performed in June and July, 2012. Serum samples from all horses 
(n=102) and horses seven months and older (n=86) were evaluated for the level of antigen 
specific IgG and IgG(T) antibodies using the optimised ELISA in separate assays. The intra-
assay variability of the ELISA was calculated from duplicate measurements from all horses. 
The inter-assay variability was calculated from the positive and negative controls included in 
each assay as well as specifically for three horses that were selected on the basis of their 
rSvSXP-specific IgG(T) OD450nm (OD value given in parentheses). These animals served as a 
high positive (2.708), an intermediate positive (1.278) and a negative (0.022). From each 
sample, a volume of 1,000 µL of serum diluted 1:50 in diluent solution was prepared to test 
triplicate samples on each of four sequential days to evaluate inter-assay variability as a 
normalised value, percentage of a positive control (PP), as previously described [43]. 
Statistical analyses 
The statistical program R, version 2.12 [44] was used to generate graphs and perform 
statistical analyses. For all statistical analyses, a P-value less than or equal to 0.05 was 
considered significant. 
Evaluation of IgG subclasses 
The non-parametric Wilcoxon rank sum test was used to compare IgG levels within each IgG 
subclass between S. vulgaris infected and uninfected horses. 
Intra- and inter-assay variability 
The intra- and inter-assay % coefficient of variability (% CV) was calculated for each series 
of assays for each of the secondary antibodies. An intra-assay % CV below 10% and an inter-
assay % CV below 20% were considered acceptable [45] 
Receiver operator characteristics (ROC) curve analysis 
ROC curve analyses were performed using the software package Epi for R [46] for two sets 
of horses: all horses (n=102) and horses seven months or older (n=86). The reason for 
excluding foals in the second analysis was due to observations of high larval counts and 
corresponding low PP-values in some of the younger foals. After excluding horses younger 
than three months of age the remaining horses were all seven months or older. The optimal 
cut-off was determined on the basis of the ROC curve analysis. 
Diagnostic accuracy 
For the two sets of horses: all horses and horses 7 months and older the software package 
EpiR for R [47] was used to calculate the diagnostic accuracy values; sensitivity, specificity, 
odds ratio, positive likelihood ratio (LR) and negative LR with corresponding 95% 
confidence intervals. 
Correlation of arterial S. vulgaris larvae and rSvSXP-specific antibodies 
The correlation between the number of S. vulgaris larvae in the cranial mesenteric artery and 
branches and the level of rSvSXP specific IgG(T)-antibodies expressed as the normalised PP-
value was evaluated by the Spearman correlation test from the software package fBasics for 
R [48]. 
All horses (n=102) were categorised by the number of larvae present in the CMA and 
branches in the following five groups: Group 0: No larvae, migratory tracts or evidence of 
previous infection (n=42); group 1: No larvae, but migratory tracts or evidence of previous 
infection (n=16); group 2: 1–5 larvae (n=16); group 3: 6–25 larvae (n=17); and group 4: 
above 25 larvae (range: 25–292) (n=11). 
A subset of the horses, horses 7 months or older (n=86), was categorised by the number of S. 
vulgaris larvae in the CMA and branches in the following five groups: Group 0: No larvae, 
migratory tracts or evidence of previous infection (n=28); group 1: Migratory tracts or 
evidence of previous infection (n=16); group 2: 1–5 larvae (n=16); group 3: 6–25 larvae 
(n=17); and group 4: above 25 larvae (range: 25–200) (n=9). 
The relationship between the different groups and the PP values was evaluated graphically 
for both sets of horses. A Kruskal-Wallis test was performed to evaluate if there was a 
significant difference between groups and a multiple comparison test after Kruskal-Wallis 
performed to identify the significantly different groups using the statistical software package 
pgirmess for R [42]. This was performed on both sets of horses. 
Results 
Preliminary characterisation of ES and rat anti-ES serum 
The silver staining of the polyacrylamide gel showed a highly diverse mixture of molecules 
in both S. vulgaris larval and adult ES (Figure 1). The hyperimmune rat serum that was raised 
against S. vulgaris adult ES recognised more molecules in the adult ES than it did in the 
larval ES (Figure 1). 
Figure 1 Silver stained gel. Lanes A+B illustrate that Strongylus vulgaris larval and adult 
excretory/secretory (ES) fractions contain a highly diverse mixture of molecules. Lane A: 
larval ES, lane B: adult ES – both stained by silver staining. To the left the low range 
molecular markers are shown. Western blot analysis: Lane C: reactivity of pre-immunisation 
rat serum against larval ES; lane D: reactivity of anti-adult S. vulgaris ES probed against 
larval ES; lane E: anti-adult S. vulgaris ES probed against adult ES; and lane F: reactivity of 
anti-adult S. vulgaris ES against larval ES. Pre-immunisation serum did not recognise 
molecules in either ES fraction (lanes C and F), and the hyperimmune serum recognised more 
molecules in adult ES (lane E) than in larval ES (lane D). To the right the low range 
molecular markers are shown. 
cDNA library and immunoscreening 
Titre analysis indicated that the primary unamplified cDNA library contained 4.75x106 
plaque forming units (pfu)/mL. Thirty plaques were randomly selected from the library, and 
PCR analysis showed that 28 of the clones had inserts (93.3%) and that 26 of the 28 (92.9%) 
had inserts larger than or equal to 500 bp. Based on BLASTx searches, sequence analysis of 
the 26 large-insert clones from the quality assessment indicated that they all coded for 
different gene products (data not shown). Horse serum from naturally infected horses was 
initially used for immunoscreening of the cDNA library; however, strong levels of anti-E. 
coli antibodies in the horse serum resulted in high background staining that could not be 
controlled (data not shown). 
The primary immunoscreening of 100,000 clones in the unamplified larval S. vulgaris cDNA 
library yielded 28 positive clones, all of which confirmed positive on secondary 
immunoscreening. The PCR products of these were all of comparable size (~ 650–680 bp, 
data not shown) and sequence results of eight slightly different sized clones confirmed that 
their cDNAs coded for the same protein. The sequence encodes 146 amino acids including a 
predicted signal peptide (18 amino acids), giving rise to a mature peptide of 128 amino acids 
with an estimated molecular weight of 13.57 kDa. No glycosylation sites were predicted and 
the protein did not have any predicted transmembrane domains. The predicted translation 
showed that the encoded protein is homologous to the SXP/RAL-2 group of nematode 
specific proteins that contain a conserved Serine-X-Proline motif giving rise to the name. The 
protein was designated SvSXP. One sequence represented a full-length cDNA coding 
sequence, which was deposited [GenBank: KC155360]. SvSXP had highest amino acid 
sequence similarity with a partial sequence from the Cylicostephanus goldi homologue, 
followed by the surface-associated antigen 2 (SAA-2) from Necator americanus [Genbank: 
ACE79378.1], and thirdly the immunodominant-hypodermal antigen AC16 from 
Ancylostoma caninum [Genbank: ABD98404.1]. Two partial sequences from a P. equorum 
derived homologue had a lesser degree of similarity (35% and 46% identities) (Figure 2a). 
Proteins of SXP-group contain a domain of unknown function (DUF148). The phylogenetic 
comparison clustered C. goldi with S. vulgaris, P. equorum with Ascaris suum and N. 
americanus with A. caninum (Figure 2b). 
Figure 2 Sequence comparison by pairwise alignment and a phylogenetic tree. a) 
ClustalOmega pairwise alignment of Strongylus vulgaris SXP (SvSXP) with homologues in 
other species. SvSXP (accession number: KC155360) is compared with Cylicostephanus 
goldi SXP partial homologue, Necator americanus surface-associated antigen (Na-SAA) 
(ACE79378.1), Ancylostoma caninum immunodominant hypodermal antigen (Ac16) 
(ABD98404.1), Ascaris suum 14 kDa antigen (As14) (BAB67769.1), Ascaris lumbricoides 
antigen 1(Ag1) (ADB45853.1) and Parascaris equorum partial homologue. The signal 
peptide for each sequence is underlined and the domain of unknown function (DUF148) is 
boxed. Asterisks (*) denote identical amino acids, double dots (:) denote conserved amino 
acid changes and a single dot (.) denotes semi-conserved amino acid changes. Hyphen (−) 
indicates that a space was inserted in the sequence to improve alignment. The percent 
similarity to SvSxP is listed for each homologous protein. b) Phylogenetic tree of the above 
mentioned sequences. 
Analysis of SvSXP in S. vulgaris larval ES 
Western blot analyses of rSvSXP and larval ES using hyperimmune guinea pig anti-rSvSXP 
serum showed that the hyperimmune serum recognised a molecule of similar size in both 
blots. The pre-immunisation guinea pig serum did not react against the 14 kDa recombinant 
antigen (Figure 3). 
Figure 3 Western blot analysis of pre-immunisation guinea pig serum (lanes A+C) and 
hyperimmune anti-rSvSXP guinea pig serum (lanes B+D) against rSvSXP (A + B) and 
Strongylus vulgaris larval excretory/secretory antigens (C + D). Hyperimmune serum 
reacted against a similar sized molecule in both antigen mixtures while pre-immunisation 
serum did not. The molecular weight markers are shown to the left of each type of antigen. 
Western blot analyses of IgG antibodies against rSvSXP in S. vulgaris-positive 
and negative horses 
The immunodiagnostic potential of antigen-specific IgG and IgG(T) antibodies against 
rSvSXP were evaluated by WB. These analyses revealed no IgG reactivity to rSvSXP in 
serum from two horses not infected with S. vulgaris (data not shown) and low level IgG(T) 
reactivity to rSvSXP in serum from eight horses not infected with S. vulgaris (Figure 4), as 
determined by post-mortem examination. In contrast, serum from seven horses infected with 
S. vulgaris showed a strong reaction to rSvSXP (Figure 4). 
Figure 4 Western blot with 233 ng recombinant SvSXP. Lanes 1–8 (box) were probed 
with serum from Strongylus vulgaris negative horse; lanes 9–15 were probed with serum 
from S. vulgaris positive horses. HRP-conjugated goat anti-horse IgG(T) antibodies (Bethyl 
Laboratories, Inc., Montgomery, TX, USA) were used as secondary antibodies. The 
molecular weight is indicated on the left size. 
Diagnostic potential of IgG subclass antibodies 
Analysis of rSvSXP-specific IgG subclasses by ELISA showed that detection of rSvSXP-
specific IgG(T) antibodies gave the clearest distinction between the seven S. vulgaris positive 
horses and the eight S. vulgaris negative horses, while the other IgG subclasses were less 
consistent (Figure 5). Both the IgG subclasses IgGa (P= 0.016) and IgG(T) (P=0.016) as well 
as total IgG (P=0.032) showed statistically significant differences between infected and non-
infected horses (n=15), whereas IgGb and IgGc did not. 
Figure 5 Boxplot showing optic density readings of the enzyme-linked immunosorbent 
assay with antigen specific IgG subclasses grouped by Strongylus vulgaris infection 
status. -: no S. vulgaris larvae; +: S. vulgaris larvae present in the cranial mesenteric artery or 
branches. The middle black line of the box is the median and the range of the box is the inter 
quartile range (IQR) giving the first and third IQR. The lower and upper lines are up to 1.5 
IQR away from the first and third quartile. Each square represents the mean OD450nm reading 
from one serum sample for each IgG subclass. Asterisks denote significant differences 
(p<0.05) between uninfected and infected horses within each IgG subclass. 
Inter- and intra-assay coefficients of variability 
The intra-assay variability of the ELISA measuring rSvSXP-specific IgG(T) antibodies was 
9.17% for all the duplicate measurements. 
For the IgG(T) assays that were included in this study the inter-assay % CV for the positive 
control was 16.9% while the inter-assay % CV for the negative control was 72.6% resulting 
in an overall inter-assay % CV of 44.8%. When using the PP-value, the overall inter-assay % 
CV dropped to 15.6%. The overall inter-assay % CV for the IgG assays, all measured on the 
same day, was 11.8%. 
Summary of horse material used for evaluation of diagnostic values of the 
ELISA 
The prevalence of arterial lesions as well as the seroprevalence in each group of horses 
described under Materials and Methods is shown in Table 1. 
  
Table 1 Prevalence of Strongylus vulgaris expressed as prevalence of arterial lesions and 
seropositive horses 





KY, naturally infected, never treated herd (n=11) 100% 90.1% 90.9% 100% 
KY, naturally infected, treated herd (n=20) 10% 5% 50% 100% 
TN, naturally infected (n=23) 73.9% 87.0% 94% 33% 
TN, experimentally infected with P. equorum (n=20) 70% 50% 64% 83% 
TN, experimentally infected with S. vulgaris and 
Cyathostomins (n=28) 
57.1% 39.3% 50% 75% 
Sensitivity (Se) and specificity (Sp) is presented for each group of horses. 
Case definition: A S. vulgaris positive horse has presence of larvae, migratory tracts or healing 
lesions. 
Cut-off value used: seropositive: PP-value above 8.75. 
A total of 42 horses showed no signs of migrating larvae in the CMA and branches or signs 
of previous infection and were classified as S. vulgaris-negative, larvae with migratory tracts 
and evidence of thrombosis were found in 47 horses, and migratory tracts or healing lesions 
were found in 19 horses, of these 10 were determined to show evidence of a previous 
infection. 
In the subset of horses seven months or older, 29 were classified as S. vulgaris-negative with 
no sign of current or previous infection; 42 horses had migrating larvae, migratory tracts and 
evidence of thrombosis; 17 horses had migratory tracts or healing lesions but no larvae, of 
these seven were determined to show evidence of a previous infection. The relationship 
between numbers of migrating arterial S. vulgaris larvae and ELISA results is illustrated in 
Figure 6. In the full dataset there was a significant difference in the level of anti-SvSXP 
IgG(T) antibodies, expressed as the PP-value, between S. vulgaris-negative horses (Group 0) 
and horses with migrating larvae (groups 2,3 and 4). In the subset of horses seven months and 
older there was a significant difference between the same groups as well as a significant 
difference between horses with no larvae but evidence of migratory tracts, aneurysm or 
healing lesions (group 1), and horses with a heavy infection (group 4). 
Figure 6 The relationship between serum anti-rSvSXP IgG(T) antibody levels 
(expressed as percentage of a positive control) and counts of migrating Strongylus 
vulgaris larvae categorised by their number of larvae. a) All 102 horses in the data set. b) 
The 86 horses in the data set aged 7 months and older. Group 0: No larvae, migratory tracts 
nor evidence of previous infection (Figure 6a: n=42; Figure 6b: n=28); group 1: Migratory 
tracts or evidence of previous infection (n=16); group 2: 1–5 larvae (n=16); group 3: 6–25 
larvae (n=17); and group 4: >25 larvae (Figure 6a: n=11; Figure 6b: n=9). The middle black 
line of the boxes is the median and the range of the box is the inter quartile range (IQR) 
giving the first and third IQR. The lower and upper lines are up to 1.5 IQR away from the 
first and third quartile. Groups with different letters are significantly different (P-value < 
0.05). 
A moderate positive correlation was found between the number of S. vulgaris larvae in the 
CMA and branches and the PP-value with an Rs of 0.5779 (0.433 – 0.693), P <0.0001 in the 
data set including all horses. In the data set including horses 7 months and older there was a 
moderate positive correlation between the number of S. vulgaris larvae in the CMA and 
branches and the PP-value with an Rs of 0.5944 (0.44 – 0.714), P<0.0001. 
Diagnostic accuracy 
The relationship between sensitivity and specificity is listed for the two datasets at different 
cut-off values (Table 2). 
Table 2 Sensitivity and specificity at different cut-off values of antibody responses 
against rSvSXP expressed as percent of a positive control (PP), using two sets of horses: 
A: all horses (n=102); B: horses 7 months or older (n=86) 
Data set A B 
PP cut-off Se$ Sp$ Se Sp 
5 0.77 0.67 0.78 0.54 
10 0.70 0.83 0.71 0.75 
15 0.64 0.88 0.66 0.82 
20 0.53 0.88 0.55 0.82 
25 0.48 0.90 0.50 0.86 
30 0.42 0.98 0.43 0.96 
40 0.37 1 0.38 1 
50 0.32 1 0.33 1 
60 0.27 1 0.28 1 
70 0.22 1 0.22 1 
80 0.17 1 0.17 1 
90 0.12 1 0.12 1 
100 0.08 1 0.09 1 
>100 0.05 1 0.02 1 
AUC$ 0.820 0.783 
$: Se: sensitivity; Sp: specificity; AUC: area under ROC curve. 
The diagnostic accuracy values expressed as sensitivity, specificity, diagnostic odds ratio, 
LR+ and LR- for each set of horses are shown for the optimal cut-off PP value in Table 3. 
Table 3 Diagnostic accuracy values with 95% confidence intervals using the same cut-
off value for two sets of horses: A: all horses (n=102); B: horses 7 months or older 
(n=86) 
Data set: A B 
Cut-off value (PP) 8.75 13.47 
Se 73.3% (60.3 – 83.9%) 65.5% (51.9 – 77.5%) 
Sp 81.0% (65.9 – 91.4%) 82.1% (63.1 – 93.9%) 
DOR 11.69 (4.48 – 30.5) 8.74 (2.89 – 26.48) 
LR+ 3.85 (2.03 – 7.32) 3.67 (1.62 – 8.30) 
LR- 0.33 (0.21 – 0.51) 0.42 (0.28 – 0.62) 
Cut-off values represent optimal sensitivity and specificity for each case-definition. PP: percent of a 
positive control; Se: sensitivity; Sp: specificity; DOR: diagnostic odds ratio; LR+: positive likelihood 
ratio; LR-: negative likelihood ratio. The 95% confidence intervals are given in parentheses. 
Discussion 
The identification of the S. vulgaris SXP protein represents a promising advancement 
towards development of a diagnostic ELISA test capable of detecting the presence of 
migrating S. vulgaris larvae in horses. In the present study, four important criteria were met 
by this protein: (i) the recombinant protein was bound by serum IgG(T) primarily from horses 
harbouring infection or exhibiting lesions associated with previous presence of S. vulgaris 
larvae; (ii) the diagnostic odds ratio of the ELISA showed that infection with migrating S. 
vulgaris larvae significantly increased the possibility of a positive test result; (iii) other 
naturally occurring equine gastrointestinal nematodes did not appear to interact with test 
results; (iv) there is evidence of a semi-quantitative relationship between infection intensity 
and ELISA results. 
Similar proteins belonging to the SXP family are expressed in other parasites infecting the 
horse, including cyathostomins and P. equorum. Cyathostomin SXPs appear to be 
phylogenetically closely related to S. vulgaris SXP, and cross-reactivity therefore remains a 
potential problem for a diagnostic test (Figure 2). Ideally, this could be tested with sera 
obtained from horses mono-specifically infected with important equine nematodes. 
Unfortunately, despite many attempts no such sera could be obtained from potential 
collaborators, and this project did not have the resources to establish such infections. It is still 
our ambition to establish such infections in the future, and these could be useful to further 
refine and optimize diagnostic performance of the test. The data generated in this study with 
horses being either naturally or experimentally infected with major equine helminth parasites. 
Although, this material illustrates room for improvement of the diagnostic parameters of the 
ELISA, it also illustrates the diagnostic potential. The experimental infections with P. 
equorum and cyathostomin parasites did not appear to dramatically affect diagnostic 
performance (Table 1). Further, four out of five of the defined subpopulations returned higher 
sensitivity than specificity, which would not have been the case if other parasites were 
stimulating a false ELISA response. It should be borne in mind that sensitivity and specificity 
for a diagnostic test depends largely on the prevalence of the target organism. Thus, there will 
always be different values in different study populations. For this reason, it is considered 
more useful to evaluate the diagnostic odds ratio (DOR) and the likelihood ratios (LR) that 
are presented in Table 3. The DORs were high and statistically significant, and the test is 
characterized by a strong positive LR. High levels of cross-reactivity with other species and 
stages would have led to more false-positive test results, and, thus, a lower positive LR. 
Taken together, rSvSXP represents a well-characterized and better validated diagnostic 
antigen for S. vulgaris diagnosis than any previously published attempt, and there is good 
reason to continue developing and refining diagnostic platforms utilizing this protein. 
As the hyperimmune rat serum was raised against adult S. vulgaris ES antigens and this was 
used to perform the immunoscreening of the S. vulgaris larval cDNA library, the protein must 
be expressed in both larval and adult stages. Thus, it is possible that adult stages in the 
intestine are also capable of affecting ELISA measurements. However, previous work with 
surgically implanted adult S. vulgaris worms in the caeca of strongyle-naïve ponies revealed 
that IgG(T) antibodies in these ponies did not differ from the non-specific background 
reactivity in strongyle-naïve controls [30]. This suggests that the immune response and hence 
antibody production is primarily stimulated by the migrating larvae and not the adult worms. 
Therefore, it remains possible that the presence of the larvae in the blood stream of the horse 
will allow a higher degree of exposure of the SXP protein to the immune system and, 
consequently, to a higher degree of production of circulating antibodies against it. More work 
is needed to investigate this further, but the fair to good relationship found between the 
number of arterial larvae and ELISA results does suggest that it is primarily the larvae that 
drive the test results. 
Previously, total IgG(T) was associated with the presence of S. vulgaris larvae [49] and 
antigen-specific IgG(T) antibodies have been shown to have immunodiagnostic potential for 
diagnosing other gastrointestinal helminths in horses [34,50,51]. In the present study, IgG(T) 
antibodies specific to rSvSXP also appeared to have a better immunodiagnostic potential than 
other IgG subclasses (Figures 5 and 6). The intra-assay % CV of mean OD450nm values was 
within acceptable levels whereas the inter-assay % CV was substantially higher. However, 
the use of the normalised PP value reduced the inter-assay % CV to within acceptable levels, 
and we therefore recommend reporting results of this assay as PP values. 
The SvSXP protein belongs to the SXP/RAL-2 group of proteins that appears to be 
nematode-specific with several proteins described in animal and plant parasitic nematodes 
[52-55]. The function of SXP/RAL-2 proteins is currently unknown. The SXP proteins have 
been shown to be potential vaccine candidates with reduced fecundity of Ancylostoma 
caninum and degree of anaemia in vaccinated dogs [56]. Additionally, SXP-proteins have 
been used for serodiagnosis of human lymphatic filariasis [53,57] and antibodies against 
BmSXP-1 and WbSXP-1 were used for detection of circulating filarial antigens [58]. This 
further supports the possibility that SvSXP possesses the essential qualities required of a 
diagnostic antigen to be applied for diagnosis of prepatent S. vulgaris infection in horses. 
Although SvSXP was the only gene identified by immunoscreening the cDNA library, the 26 
randomly amplified and sequenced cDNA clones from the quality assessment step were all 
unique, suggesting that the library is heterogeneous. It seems likely that the SvSXP protein is 
highly immunogenic so that antiserum raised against ES contains a high proportion of anti-
SvSXP antibodies. 
The semi-quantitative potential of the test is illustrated in Figure 6. We performed a separate 
analysis in horses older than seven months to evaluate if the ELISA would perform better in 
this age group. Indeed, when comparing Figure 6a and b there seems to be a better agreement 
between the larval burden and the PP-value when foals were excluded. This illustrates that 
younger foals can harbour a large number of migrating larvae without producing antibody 
titres, and more studies are needed to explain this finding. However, it should be noted that 
the AUC of the ROC curves and the diagnostic values calculated from both datasets are not 
significantly different from each other. Thus, more studies are needed to identify a possible 
minimum age for the use of the ELISA. 
The ELISA performed with a sensitivity and specificity comparable to larval cultures carried 
out for detection of S. vulgaris eggs [59], but has the potential for also reflecting arterial 
larvae. The odds of a PP-value above the cut-off among horses with migrating S. vulgaris 
larvae, migratory tracts or evidence of previous infection was 11.7 times higher than the odds 
of a similar ELISA result among horses without migrating S. vulgaris larvae or signs thereof. 
Moreover, a high PP-value indicates a high number of migrating larvae (Figure 6). Even 
though the sensitivity and specificity are moderate to good, the false negative samples still 
comprise roughly a fifth of the samples at the optimised cut-off value. For a rare, potentially 
life-threatening disease the optimal assay would be a highly sensitive test, especially when 
used at an individual level. This will, however, lead to treatment of 19% of horses with no 
current infection with S. vulgaris. If the test is to function as a screening tool on a herd level 
it requires a high specificity and the resulting lowered sensitivity in this assay can be 
counteracted by increasing the number of horses sampled. Table 2 can be used to optimise the 
interpretation of the test-result on both an individual level and a herd level. 
Conclusion 
In conclusion, we have identified a promising candidate antigen for diagnosing S. vulgaris 
infection at the prepatent stage. Our work illustrates that SvSXP is highly immunogenic and 
that IgG(T) antibodies specific for rSvSXP had the highest diagnostic potential both in WB 
analysis as well as in an indirect ELISA. 
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